Kavli Oxford Lecture Award 2025 - Dr Daniel M. Skovronsky
Kavli Oxford Lecture Award 2025 - Daniel M. Skovronsky
The fourth Kavli Oxford Lecture Award will be given by Daniel M. Skovronsky, MD, Phd, Chief Scientific Officer and head of research and development at Ely Lilly and Company
Hosted by Kavli Oxford's Founding Director, Professor Dame Carol Robinson, join Dr Skovronsky for a review of the long history behind research into metabolic hormones and how the field is continuing to evolve.
The lecture will take place on Monday 24 November 2025 at 16h30 in the Blakemore Lecture Theatre, Department of Physiology, Anatomy and Genetics, Sherrington Road, Oxford followed by a drinks reception at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, Sherrington Road, Oxford.
*Open to University of Oxford staff and students only - entry to both buildings is strictly on presentation of University Bodleian card
*Please note that seating is limited to 190 attendees
*The lecture is in person only, and will start at 16:30 sharp, please note that late arrivals cannot be accommodated
Dr Skovronsky joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since founding the company in 2004. At Lilly, he has held various leadership roles, including chief medical officer; vice president, tailored therapeutics; vice president, diabetes research; and senior vice president, clinical and product development.
Dr Skovronsky completed his residency training in pathology and fellowship training in neuropathology at the Hospital of the University of Pennsylvania. He received his M.D. from the Perelman School of Medicine, University of Pennsylvania, in 2001, and his Ph.D. in neuroscience from University of Pennsylvania in 2000. Dr Skovronsky earned a Bachelor of Science in molecular biophysics and biochemistry from Yale University in 1994.
For interest, details about previous recipients of the Kavli Oxford Lecture Award is available on our website.
We hope to see you!
